Dianthus Therapeutics, Inc. /DE/ (DNTH) Net margin 2021–2025
Dianthus Therapeutics, Inc. /DE/ (DNTH) net profit margin by fiscal year — reported net income divided by reported revenue.
-7973.3%FY2025 · since FY2021: -4819.5% → -7973.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -7973.3% | -6610.6 pp |
| FY2024 | -1362.8% | +178.4 pp |
| FY2023 | -1541.2% | -1097.5 pp |
| FY2022 | -443.8% | +4375.8 pp |
| FY2021 | -4819.5% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More DNTH financial trends
DNTH RevenueDNTH Net incomeDNTH Gross profitDNTH Gross marginDNTH Operating incomeDNTH Operating marginDNTH Operating cash flowDNTH Free cash flowDNTH Capital expendituresDNTH Return on equityDNTH Stock buybacksDNTH Dividends paidDNTH Total assetsDNTH Total liabilitiesDNTH Shareholders’ equityDNTH overview →